Perspective Therapeutics (CATX) Shares Outstanding (2011 - 2026)

Perspective Therapeutics has disclosed Shares Outstanding across 16 years of filings, most recently posting $114.0 million for Q1 2026.

• Shares Outstanding for Q1 2026 came in at $114.0 million, up 53.97% year-over-year; the trailing twelve-month figure through Mar 2026 was $114.0 million (up 53.97% YoY), and the FY2025 annual result was $74.3 million, up 5.19% from the prior year.
• Shares Outstanding came in at $114.0 million for Q1 2026 at Perspective Therapeutics, up from $74.3 million in the prior quarter.
• In the past five years, Shares Outstanding ranged from a high of $142.1 million in Q3 2022 to a low of $14.2 million in Q4 2022.
• The 5-year median for Shares Outstanding is $70.7 million (2024), against an average of $72.2 million.
• Across the five-year window, Shares Outstanding sank 89.99% in 2022 and surged 150.78% in 2024, its largest moves.
• Perspective Therapeutics' Shares Outstanding stood at $14.2 million in 2022, then soared by 98.3% to $28.2 million in 2023, then soared by 150.78% to $70.7 million in 2024, then grew by 5.19% to $74.3 million in 2025, then surged by 53.38% to $114.0 million in 2026.
• The last three Shares Outstanding figures came in at $114.0 million (Q1 2026), $74.3 million (Q4 2025), and $74.3 million (Q3 2025), per Business Quant data.